FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to internal medicine. In women, the values of four indicators are determined: weight, body mass index (BMI), hip volume (HV) and triglyceride (TG) level in a blood sample. The obtained values are compared with the threshold values of the corresponding indicators, and when three or more values of the indicators exceeding the threshold values of the corresponding indicators are obtained, a conclusion is made about the high risk of developing a severe course of the new coronavirus infection.
EFFECT: method makes it possible to simplify the assessment of the risk of developing a severe course of a new coronavirus infection, which will ensure the correct choice of patient management tactics and early prevention of complications of coronavirus infection in the risk group.
1 cl, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ASSESSING THE RISK OF DEVELOPING A SEVERE COURSE OF CoVID-19 | 2022 |
|
RU2782796C1 |
| METHOD OF PREDICTING PRETERM LABOR IN WOMEN WITH PNEUMONIA IN THE THIRD TRIMESTER CAUSED BY SARS-CoV-2 | 2023 |
|
RU2801031C1 |
| METHOD OF PREDICTING THE RISK OF DEATH FROM COVID-19 IN YOUNG PATIENTS | 2023 |
|
RU2803002C1 |
| METHOD OF PREDICTING COMPLICATIONS AFTER COVID-19 IN PERSONS WITH COMORBID BACKGROUND IN THE ARCTIC REGION | 2023 |
|
RU2812780C1 |
| METHOD FOR PERSONIFIED PREDICTION OF FATAL OUTCOMES OF COVID-19-ASSOCIATED PNEUMONIA IN ELDERLY AND SENILE PATIENTS | 2023 |
|
RU2817106C1 |
| METHOD FOR DIAGNOSING THROMBINEMIA IN PATIENTS WITH COVID-19 INFECTION | 2022 |
|
RU2794035C1 |
| METHOD FOR DIAGNOSING MACROPHAGE ACTIVATION SYNDROME IN A NEW CORONAVIRUS INFECTION CAUSED BY THE SARS VIRUS - COV-2 | 2022 |
|
RU2778779C1 |
| METHOD OF TREATING COVID-19 IN CHILDREN AT RISK OF SEVERE CLINICAL COURSE OF DISEASE | 2023 |
|
RU2815303C1 |
| METHOD FOR PREDICTING THE RISK OF SEVERE COVID-19 IN A PATIENT | 2022 |
|
RU2791487C1 |
| METHOD OF PREDICTING THE RISK OF DEVELOPING CHRONIC HEART FAILURE IN PATIENTS WHO HAVE HAD A NEW CORONAVIRUS INFECTION COVID-19 | 2023 |
|
RU2805601C1 |
